Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V0114 dose-ranging study in seasonal allergic rhinitis
2005-005975-13Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of levocetirizine in seasonal allergic rhinitis (SAR) (6 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Nasal symptom score. Started Mar 2006; status: completed.
02
Drugs
levocetirizine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2005-005975-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005975-13.